Status:
UNKNOWN
Antiretroviral Adherence and Drug-level Monitoring
Lead Sponsor:
Zamrotul Izzah
Collaborating Sponsors:
Universitas Airlangga
Conditions:
HIV Infections
AIDS
Eligibility:
All Genders
18+ years
Brief Summary
This observational study aims to investigate medication adherence and drug-level monitoring of antiretroviral agents in a cohort of people living with HIV in Indonesia. The study is conducted in outpa...
Detailed Description
Optimal adherence is critical to achieve and sustain viral suppression. Currently, there is no gold standard measure of antiretroviral adherence and exposure in clinical practice. Recent studies have ...
Eligibility Criteria
Inclusion
- Adults with HIV who have been receiving antiretroviral therapy containing tenofovir-based regimens for at least six months
Exclusion
- Pregnant and breastfeeding women, people with kidney failure, undergoing hemodialysis or peritoneal dialysis, uncontrolled diabetes, uncontrolled hypertension, and hypersensitivity to tenofovir
Key Trial Info
Start Date :
October 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05996094
Start Date
October 16 2020
End Date
December 31 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitas Airlangga Hospital
Surabaya, East Java, Indonesia, 60115